 | • レポートコード：MRC23Q37873 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の生理痛緩和製品市場について調査・分析し、世界の生理痛緩和製品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（一次性月経困難症、二次性月経困難症）、用途別セグメント分析（個人、病院、専門センター、外来手術センター、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Bayer AG、GlaxoSmithKline plc、Pfizer Inc.、Pee Safe、Sanfe、SanNap、LIVIA、Abbott Healthcareなどが含まれています。世界の生理痛緩和製品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、生理痛緩和製品市場規模を推定する際に考慮しました。本レポートは、生理痛緩和製品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、生理痛緩和製品に関するビジネス上の意思決定に役立てることを目的としています。 ・生理痛緩和製品市場の概要 - 製品の定義 - 生理痛緩和製品のタイプ別セグメント - 世界の生理痛緩和製品市場規模：タイプ別分析（一次性月経困難症、二次性月経困難症） - 生理痛緩和製品の用途別セグメント - 世界の生理痛緩和製品市場規模：用途別分析（個人、病院、専門センター、外来手術センター、その他） - 世界の生理痛緩和製品市場規模予測（2018年-2029年） - 生理痛緩和製品の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 生理痛緩和製品市場の競争状況およびトレンド ・生理痛緩和製品の地域別市場規模 - 北米の生理痛緩和製品市場規模（2018年-2029年） - アメリカの生理痛緩和製品市場規模（2018年-2029年） - ヨーロッパの生理痛緩和製品市場規模（2018年-2029年） - アジア太平洋の生理痛緩和製品市場規模（2018年-2029年） - 中国の生理痛緩和製品市場規模（2018年-2029年） - 日本の生理痛緩和製品市場規模（2018年-2029年） - 韓国の生理痛緩和製品市場規模（2018年-2029年） - インドの生理痛緩和製品市場規模（2018年-2029年） - オーストラリアの生理痛緩和製品市場規模（2018年-2029年） - 中南米の生理痛緩和製品市場規模（2018年-2029年） - 中東・アフリカの生理痛緩和製品市場規模（2018年-2029年） ・タイプ別セグメント：一次性月経困難症、二次性月経困難症 - 世界の生理痛緩和製品のタイプ別販売量（2018年-2023年） - 世界の生理痛緩和製品のタイプ別売上（2018年-2023年） - 世界の生理痛緩和製品のタイプ別価格 ・用途別セグメント：個人、病院、専門センター、外来手術センター、その他 - 世界の生理痛緩和製品の用途別販売量（2018年-2023年） - 世界の生理痛緩和製品の用途別売上（2018年-2023年） - 世界の生理痛緩和製品の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Bayer AG、GlaxoSmithKline plc、Pfizer Inc.、Pee Safe、Sanfe、SanNap、LIVIA、Abbott Healthcare ・産業チェーンと販売チャネルの分析 - 生理痛緩和製品産業チェーン分析 - 生理痛緩和製品の主要原材料 - 生理痛緩和製品の販売チャネル - 生理痛緩和製品のディストリビューター - 生理痛緩和製品の主要顧客 ・生理痛緩和製品市場ダイナミクス - 生理痛緩和製品の業界動向 - 生理痛緩和製品市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Menstrual cramps refer to the severe cramps experienced in the lower abdomen that could extend down to the back and lower legs. Majority of women start experiencing acute pain during their early adolescence, around the first five years of the beginning of the menstrual cycle. This is also called Dysmenorrhea in medical terms.
Highlights
The global Menstrual Cramps Relief Product market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Menstrual Cramps Relief Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Menstrual Cramps Relief Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Menstrual Cramps Relief Product include Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Pee Safe, Sanfe, SanNap, LIVIA and Abbott Healthcare, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Menstrual Cramps Relief Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menstrual Cramps Relief Product.
The Menstrual Cramps Relief Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Menstrual Cramps Relief Product market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menstrual Cramps Relief Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bayer AG
GlaxoSmithKline plc
Pfizer Inc.
Pee Safe
Sanfe
SanNap
LIVIA
Abbott Healthcare
Segment by Type
Primary Dysmenorrhea
Secondary Dysmenorrhea
Segment by Application
Individuals
Hospitals
Specialty Centers
Ambulatory Surgical Centers
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Menstrual Cramps Relief Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Menstrual Cramps Relief Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Menstrual Cramps Relief Product Market Overview
1.1 Product Overview and Scope of Menstrual Cramps Relief Product
1.2 Menstrual Cramps Relief Product Segment by Type
1.2.1 Global Menstrual Cramps Relief Product Market Value Comparison by Type (2023-2029)
1.2.2 Primary Dysmenorrhea
1.2.3 Secondary Dysmenorrhea
1.3 Menstrual Cramps Relief Product Segment by Application
1.3.1 Global Menstrual Cramps Relief Product Market Value by Application: (2023-2029)
1.3.2 Individuals
1.3.3 Hospitals
1.3.4 Specialty Centers
1.3.5 Ambulatory Surgical Centers
1.3.6 Others
1.4 Global Menstrual Cramps Relief Product Market Size Estimates and Forecasts
1.4.1 Global Menstrual Cramps Relief Product Revenue 2018-2029
1.4.2 Global Menstrual Cramps Relief Product Sales 2018-2029
1.4.3 Global Menstrual Cramps Relief Product Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Menstrual Cramps Relief Product Market Competition by Manufacturers
2.1 Global Menstrual Cramps Relief Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global Menstrual Cramps Relief Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Menstrual Cramps Relief Product Average Price by Manufacturers (2018-2023)
2.4 Global Menstrual Cramps Relief Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Menstrual Cramps Relief Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Menstrual Cramps Relief Product, Product Type & Application
2.7 Menstrual Cramps Relief Product Market Competitive Situation and Trends
2.7.1 Menstrual Cramps Relief Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Menstrual Cramps Relief Product Players Market Share by Revenue
2.7.3 Global Menstrual Cramps Relief Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Menstrual Cramps Relief Product Retrospective Market Scenario by Region
3.1 Global Menstrual Cramps Relief Product Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Menstrual Cramps Relief Product Global Menstrual Cramps Relief Product Sales by Region: 2018-2029
3.2.1 Global Menstrual Cramps Relief Product Sales by Region: 2018-2023
3.2.2 Global Menstrual Cramps Relief Product Sales by Region: 2024-2029
3.3 Global Menstrual Cramps Relief Product Global Menstrual Cramps Relief Product Revenue by Region: 2018-2029
3.3.1 Global Menstrual Cramps Relief Product Revenue by Region: 2018-2023
3.3.2 Global Menstrual Cramps Relief Product Revenue by Region: 2024-2029
3.4 North America Menstrual Cramps Relief Product Market Facts & Figures by Country
3.4.1 North America Menstrual Cramps Relief Product Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Menstrual Cramps Relief Product Sales by Country (2018-2029)
3.4.3 North America Menstrual Cramps Relief Product Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Menstrual Cramps Relief Product Market Facts & Figures by Country
3.5.1 Europe Menstrual Cramps Relief Product Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Menstrual Cramps Relief Product Sales by Country (2018-2029)
3.5.3 Europe Menstrual Cramps Relief Product Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Menstrual Cramps Relief Product Market Facts & Figures by Country
3.6.1 Asia Pacific Menstrual Cramps Relief Product Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Menstrual Cramps Relief Product Sales by Country (2018-2029)
3.6.3 Asia Pacific Menstrual Cramps Relief Product Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Menstrual Cramps Relief Product Market Facts & Figures by Country
3.7.1 Latin America Menstrual Cramps Relief Product Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Menstrual Cramps Relief Product Sales by Country (2018-2029)
3.7.3 Latin America Menstrual Cramps Relief Product Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Menstrual Cramps Relief Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Menstrual Cramps Relief Product Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Menstrual Cramps Relief Product Sales by Country (2018-2029)
3.8.3 Middle East and Africa Menstrual Cramps Relief Product Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Menstrual Cramps Relief Product Sales by Type (2018-2029)
4.1.1 Global Menstrual Cramps Relief Product Sales by Type (2018-2023)
4.1.2 Global Menstrual Cramps Relief Product Sales by Type (2024-2029)
4.1.3 Global Menstrual Cramps Relief Product Sales Market Share by Type (2018-2029)
4.2 Global Menstrual Cramps Relief Product Revenue by Type (2018-2029)
4.2.1 Global Menstrual Cramps Relief Product Revenue by Type (2018-2023)
4.2.2 Global Menstrual Cramps Relief Product Revenue by Type (2024-2029)
4.2.3 Global Menstrual Cramps Relief Product Revenue Market Share by Type (2018-2029)
4.3 Global Menstrual Cramps Relief Product Price by Type (2018-2029)
5 Segment by Application
5.1 Global Menstrual Cramps Relief Product Sales by Application (2018-2029)
5.1.1 Global Menstrual Cramps Relief Product Sales by Application (2018-2023)
5.1.2 Global Menstrual Cramps Relief Product Sales by Application (2024-2029)
5.1.3 Global Menstrual Cramps Relief Product Sales Market Share by Application (2018-2029)
5.2 Global Menstrual Cramps Relief Product Revenue by Application (2018-2029)
5.2.1 Global Menstrual Cramps Relief Product Revenue by Application (2018-2023)
5.2.2 Global Menstrual Cramps Relief Product Revenue by Application (2024-2029)
5.2.3 Global Menstrual Cramps Relief Product Revenue Market Share by Application (2018-2029)
5.3 Global Menstrual Cramps Relief Product Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Menstrual Cramps Relief Product Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Corporation Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline plc Menstrual Cramps Relief Product Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Inc. Menstrual Cramps Relief Product Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Pee Safe
6.4.1 Pee Safe Corporation Information
6.4.2 Pee Safe Description and Business Overview
6.4.3 Pee Safe Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pee Safe Menstrual Cramps Relief Product Product Portfolio
6.4.5 Pee Safe Recent Developments/Updates
6.5 Sanfe
6.5.1 Sanfe Corporation Information
6.5.2 Sanfe Description and Business Overview
6.5.3 Sanfe Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanfe Menstrual Cramps Relief Product Product Portfolio
6.5.5 Sanfe Recent Developments/Updates
6.6 SanNap
6.6.1 SanNap Corporation Information
6.6.2 SanNap Description and Business Overview
6.6.3 SanNap Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 SanNap Menstrual Cramps Relief Product Product Portfolio
6.6.5 SanNap Recent Developments/Updates
6.7 LIVIA
6.6.1 LIVIA Corporation Information
6.6.2 LIVIA Description and Business Overview
6.6.3 LIVIA Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LIVIA Menstrual Cramps Relief Product Product Portfolio
6.7.5 LIVIA Recent Developments/Updates
6.8 Abbott Healthcare
6.8.1 Abbott Healthcare Corporation Information
6.8.2 Abbott Healthcare Description and Business Overview
6.8.3 Abbott Healthcare Menstrual Cramps Relief Product Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbott Healthcare Menstrual Cramps Relief Product Product Portfolio
6.8.5 Abbott Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Menstrual Cramps Relief Product Industry Chain Analysis
7.2 Menstrual Cramps Relief Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Menstrual Cramps Relief Product Production Mode & Process
7.4 Menstrual Cramps Relief Product Sales and Marketing
7.4.1 Menstrual Cramps Relief Product Sales Channels
7.4.2 Menstrual Cramps Relief Product Distributors
7.5 Menstrual Cramps Relief Product Customers
8 Menstrual Cramps Relief Product Market Dynamics
8.1 Menstrual Cramps Relief Product Industry Trends
8.2 Menstrual Cramps Relief Product Market Drivers
8.3 Menstrual Cramps Relief Product Market Challenges
8.4 Menstrual Cramps Relief Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer